Correspondence 0001193125-23-296749 from Harpoon Therapeutics, Inc. (CIK 0001708493)
Harpoon Therapeutics, Inc. (CIK 0001708493)
Date: Dec. 15, 2023 · CIK: 0001708493 · Accession: 0001193125-23-296749
AI Filing Summary & Sentiment
File numbers found in text: 333-275958
Letter
Re: Harpoon Therapeutics, Inc.
December 15, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Alan Campbell
Registration Statement on Form S-3
File No. 333-275958
Acceleration Request
Requested Date: December 19, 2023
Requested Time: 4:00 PM Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the Registration Statement on Form S-3 (File No. 333-275958) (the “Registration Statement”) to become effective on Tuesday, December 19, 2023 at 4:00 p.m. Eastern Time, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission (the “Staff”). The Registrant hereby authorizes each of Courtney M.W. Tygesson and Marina Remennik of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Courtney M.W. Tygesson of Cooley LLP, counsel to the Registrant, at (312) 881-6680, or in her absence, Marina Remennik at (650) 843-5124.
Very truly yours,
HARPOON THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP December 15, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Alan Campbell Re: Harpoon Therapeutics, Inc. Registration Statement on Form S-3 File No. 333-275958 Acceleration Request Requested Date: December 19, 2023 Requested Time: 4:00 PM Eastern Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the Registration Statement on Form S-3 (File No. 333-275958) (the “Registration Statement”) to become effective on Tuesday, December 19, 2023 at 4:00 p.m. Eastern Time, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission (the “Staff”). The Registrant hereby authorizes each of Courtney M.W. Tygesson and Marina Remennik of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Courtney M.W. Tygesson of Cooley LLP, counsel to the Registrant, at (312) 881-6680, or in her absence, Marina Remennik at (650) 843-5124. Very truly yours, HARPOON THERAPEUTICS, INC. By: /s/ Julie Eastland Name: Julie Eastland Title: President and Chief Executive Officer cc: Courtney M.W. Tygesson, Cooley LLP Marina Remennik, Cooley LLP